Clinical Trial Update: Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus Challenge [Phase 2]

View source ↗

Summary

Phase IIa trial assessing intranasal ETH47 for reducing asthma-related symptoms after rhinovirus challenge in people with asthma; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ETH47

Snippet

Sponsor: Ethris GmbH | Conditions: Asthma (Diagnosis) | Phase 2 | Status: RECRUITING